AbbVie and Genmab’s Epkinly shows outpatient viability in Phase II trial
According to experts, the ability to dose Epkinly in the outpatient setting could provide broader access to the drug.
04 September 2025
04 September 2025
According to experts, the ability to dose Epkinly in the outpatient setting could provide broader access to the drug.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.